Technical Analysis for ENTA - Enanta Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade A 79.41 0.09% 0.07
ENTA closed up 0.09 percent on Thursday, February 22, 2018, on 60 percent of normal volume.
1 Watcher
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ENTA trend table...

Date Alert Name Type % Chg
Feb 21 Multiple of Ten Bearish Other 0.09%
Feb 21 Inside Day Range Contraction 0.09%
Feb 21 Wide Bands Range Expansion 0.09%
Feb 20 Multiple of Ten Bearish Other 1.86%
Feb 20 Wide Bands Range Expansion 1.86%
Feb 16 Calm After Storm Range Contraction -2.66%
Feb 16 Doji - Bearish? Reversal -2.66%
Feb 16 Wide Bands Range Expansion -2.66%
Feb 16 Up 3 Days in a Row Strength -2.66%
Feb 16 Up 4 Days in a Row Strength -2.66%

Older signals for ENTA ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Enanta Pharmaceuticals, Inc., a biotechnology company, engages in the development of small molecule drugs for the infectious disease areas. Its product candidates include ABT-450, an inhibitor of NS3 protease that is in Phase III clinical trials for the treatment of hepatitis C virus (HCV) infection; EDP-239, an NS5A Inhibitor for HCV infection; EDP-546, a Cyclophilin inhibitor, which is in preclinical studies for HCV infection treatment; and Nucleotide Polymerase inhibitor for HCV infection. The company also develops EDP-788, an intravenous drug for the treatment of methicillin-resistant Staphylococcus aureus bacteria. It has collaboration and license agreements with Novartis Institutes for BioMedical Research, Inc. and Abbott Laboratories. The company was founded in 1995 and is headquartered in Watertown, Massachusetts.
Is ENTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 95.91
52 Week Low 27.24
Average Volume 220,763
200-Day Moving Average 47.8629
50-Day Moving Average 68.4506
20-Day Moving Average 81.6065
10-Day Moving Average 78.278
Average True Range 4.1523
ADX 27.75
+DI 24.02
-DI 23.15
Chandelier Exit (Long, 3 ATRs ) 83.4531
Chandelier Exit (Short, 3 ATRs ) 82.4369
Upper Bollinger Band 92.02
Lower Bollinger Band 71.193
Percent B (%b) 0.39
BandWidth 25.521251
MACD Line 2.9308
MACD Signal Line 4.1925
MACD Histogram -1.2617
Fundamentals Value
Market Cap 1.52 Billion
Num Shares 19.1 Million
EPS -1.08
Price-to-Earnings (P/E) Ratio -73.53
Price-to-Sales 23.12
Price-to-Book 3.52
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 83.63
Resistance 3 (R3) 83.83 82.63 82.92
Resistance 2 (R2) 82.63 81.56 82.53 82.69
Resistance 1 (R1) 81.02 80.89 80.42 80.82 82.45
Pivot Point 79.82 79.82 79.52 79.72 79.82
Support 1 (S1) 78.21 78.75 77.61 78.01 76.37
Support 2 (S2) 77.01 78.08 76.91 76.13
Support 3 (S3) 75.40 77.01 75.90
Support 4 (S4) 75.20